Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00910637 · ClinicalTrials.gov registry record · Phase 3
Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles
A Phase 3 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,502
- Enrollment target
NCT00910637 is a Phase 3 study that has completed, run by Bayer. The registered enrollment target is 1,502 participants.
The verdict
NCT00910637, a Phase 3 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,502 participants
- Enrollment target
Study Summary
This study is examining a birth control patch for 13 cycles (1 year).
Interventions
- DRUG Gestodene/EE Patch (BAY86-5016)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,502 participants |
| Start Date | 2009-05-01 |
| Est. Completion | 2010-12-13 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00910637
The ClinicalTrials.gov registry entry for NCT00910637 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,502 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gestodene/EE Patch (BAY86-5016) is the first listed.
NCT00910637 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00910637 about?
NCT00910637 is a clinical study titled "Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles". This study is examining a birth control patch for 13 cycles (1 year).
What is the current status of trial NCT00910637?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,502 participants. The study started on 2009-05-01. Estimated completion is 2010-12-13.
What interventions are being tested in trial NCT00910637?
The interventions under investigation include: Gestodene/EE Patch (BAY86-5016) (DRUG).
Who is sponsoring clinical trial NCT00910637?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.